Original Research
Published on 12 Dec 2025
A real-world disproportionality analysis of roflumilast using the US food and drug administration adverse event reporting system data
in Respiratory Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1721656
- 710 views